Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0001683168-23-007809
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$2.78M | -$3.58M | -$3.74M | -$2.31M |
| EPS Diluted |
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
| -$10.25 |
| -$3.14 |
| -$0.28 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.